01 1Sichuan Mol Biopharma Co., Ltd.
01 1Iksoo Pharmaceutical Co., Ltd.
01 1Levocloperastine phendisoate
01 1Blank
Registrant Name : Iksoo Pharmaceutical Co., Ltd.
Registration Date : 2022-11-08
Registration Number : 20221108-209-J-1399
Manufacturer Name : Sichuan Mol Biopharma Co., L...
Manufacturer Address : No.51, Industrial Road, Heshan Town, Pujiang, Chengdu
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
A Levocloperastine Fendizoate manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Levocloperastine Fendizoate, including repackagers and relabelers. The FDA regulates Levocloperastine Fendizoate manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Levocloperastine Fendizoate API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Levocloperastine Fendizoate manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Levocloperastine Fendizoate supplier is an individual or a company that provides Levocloperastine Fendizoate active pharmaceutical ingredient (API) or Levocloperastine Fendizoate finished formulations upon request. The Levocloperastine Fendizoate suppliers may include Levocloperastine Fendizoate API manufacturers, exporters, distributors and traders.
click here to find a list of Levocloperastine Fendizoate suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
In Korea, the Ministry of Food and Drug Safety (MFDS) is in charge of regulating pharmaceutical products and services.
Pharmaceutical companies submit a Levocloperastine Fendizoate Drug Master File in Korea (Levocloperastine Fendizoate KDMF) to the MFDS, which includes comprehensive information about the production, processing, facilities, materials, packaging, and testing of Levocloperastine Fendizoate. The MFDS reviews the Levocloperastine Fendizoate KDMF as part of the drug registration process and uses the information provided in the Levocloperastine Fendizoate KDMF to evaluate the safety and efficacy of the drug.
After submitting a Levocloperastine Fendizoate KDMF to the MFDS, the registered manufacturer can provide importers or distributors with the registration number without revealing confidential information to Korean business partners. Applicants seeking to register their Levocloperastine Fendizoate API can apply through the Korea Drug Master File (KDMF).
click here to find a list of Levocloperastine Fendizoate suppliers with KDMF on PharmaCompass.
LOOKING FOR A SUPPLIER?